Semin Musculoskelet Radiol 2010; 14(1): 047-056
DOI: 10.1055/s-0030-1248704
© Thieme Medical Publishers

Whole-Body Magnetic Resonance Imaging in Skeletal Muscle Disease

Martin J. Shelly1 , Ferdia Bolster1 , Paul Foran1 , Ian Crosbie1 , Eoin C. Kavanagh1 , 2 , Stephen J. Eustace1 , 2 , 3
  • 1Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland
  • 2Department of Radiology, Cappagh National Orthopaedic Hospital, Finglas, Dublin, Ireland
  • 3Department of Radiology, University College Dublin, Dublin, Ireland
Further Information

Publication History

Publication Date:
12 March 2010 (online)

ABSTRACT

The evaluation of muscle diseases has traditionally integrated clinical with biochemical findings, occasionally resorting to muscle biopsy. This article reviews the role and imaging appearances of muscle diseases at MRI, specifically emphasising the role of WBMRI in global assessment of muscle abnormality, and in particular its role in determining distribution and extent of muscle abnormality.

REFERENCES

  • 1 Farber J M, Buckwalter K A. MR imaging in nonneoplastic muscle disorders of the lower extremity.  Radiol Clin North Am. 2002;  40(5) 1013-1031
  • 2 Ahn J M, El-Khoury G Y. Role of magnetic resonance imaging in musculoskeletal trauma.  Top Magn Reson Imaging. 2007;  18(3) 155-168
  • 3 Schmidt G P, Reiser M F, Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging.  Skeletal Radiol. 2007;  36(12) 1109-1119
  • 4 Chan W P, Liu G C. MR imaging of primary skeletal muscle diseases in children.  AJR Am J Roentgenol. 2002;  179(4) 989-997
  • 5 Napier N, Shortt C, Eustace S. Muscle edema: classification, mechanisms, and interpretation.  Semin Musculoskelet Radiol. 2006;  10(4) 258-267
  • 6 Rybak L D, Torriani M. Magnetic resonance imaging of sports-related muscle injuries.  Top Magn Reson Imaging. 2003;  14(2) 209-219
  • 7 May D A, Disler D G, Jones E A, Balkissoon A A, Manaster B J. Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls.  Radiographics. 2000;  20(Spec No) S295-S315
  • 8 Snell R S. Introduction. In: Clinical Anatomy for Medical Students. 5th ed. Boston, MA; Little, Brown 1995: 1-45
  • 9 Adams E M, Chow C K, Premkumar A, Plotz P H. The idiopathic inflammatory myopathies: spectrum of MR imaging findings.  Radiographics. 1995;  15(3) 563-574
  • 10 Dahnert W. Radiology Review Manual. 6th ed. Philadelphia, PA; Lippincott Williams & Wilkins 2007
  • 11 Curiel R V, Jones R, Brindle K. Magnetic resonance imaging of the idiopathic inflammatory myopathies: structural and clinical aspects.  Ann N Y Acad Sci. 2009;  1154 101-114
  • 12 Weckbach S. Whole-body MR imaging for patients with rheumatism.  Eur J Radiol. 2009;  70(3) 431-441
  • 13 Hargaden G, O'Connell M, Kavanagh E, Powell T, Ward R, Eustace S. Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging.  AJR Am J Roentgenol. 2003;  180(1) 247-252
  • 14 O'Connell M J, Powell T, Brennan D, Lynch T, McCarthy C J, Eustace S J. Whole-body MR imaging in the diagnosis of polymyositis.  AJR Am J Roentgenol. 2002;  179(4) 967-971
  • 15 Dalakas M C, Hohlfeld R. Polymyositis and dermatomyositis.  Lancet. 2003;  362(9388) 971-982
  • 16 Wong E H, Hui A C, Griffith J F, Wong S M, Szeto C C. MRI in biopsy-negative dermatomyositis.  Neurology. 2005;  64(4) 750
  • 17 Connor A, Stebbings S, Anne Hung N, Hammond-Tooke G, Meikle G, Highton J. STIR MRI to direct muscle biopsy in suspected idiopathic inflammatory myopathy.  J Clin Rheumatol. 2007;  13(6) 341-345
  • 18 Tomasová Studynková J, Charvát F, Jarosová K, Vencovsky J. The role of MRI in the assessment of polymyositis and dermatomyositis.  Rheumatology (Oxford). 2007;  46(7) 1174-1179
  • 19 Schweitzer M E, Fort J. Cost-effectiveness of MR imaging in evaluating polymyositis.  AJR Am J Roentgenol. 1995;  165(6) 1469-1471
  • 20 Lundberg I E, Alexanderson H. Technology insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies.  Nat Clin Pract Rheumatol. 2007;  3(5) 282-290
  • 21 Olsen N J, Qi J, Park J H. Imaging and skeletal muscle disease.  Curr Rheumatol Rep. 2005;  7(2) 106-114
  • 22 Tzaribachev N, Well C, Schedel J, Horger M. Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature.  Rheumatol Int. 2009;  29(12) 1511-1514
  • 23 Lovitt S, Moore S L, Marden F A. The use of MRI in the evaluation of myopathy.  Clin Neurophysiol. 2006;  117(3) 486-495
  • 24 Walker U A. Imaging tools for the clinical assessment of idiopathic inflammatory myositis.  Curr Opin Rheumatol. 2008;  20(6) 656-661
  • 25 Maillard S M, Jones R, Owens C et al.. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.  Rheumatology (Oxford). 2004;  43(5) 603-608
  • 26 Kumar V AA, Fausto N, Aster J. Acute and chronic inflammation. In: Kumar VAA, Fausto N, Aster J Robbins and Cotran Pathologic Basis of Disease. 8th ed. Philadelphia, PA; Saunders 2010: 43-77
  • 27 Dalakas M C. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies.  Nat Clin Pract Rheumatol. 2006;  2(4) 219-227
  • 28 Bohan A, Peter J B. Polymyositis and dermatomyositis (first of two parts).  N Engl J Med. 1975;  292(7) 344-347
  • 29 Bohan A, Peter J B. Polymyositis and dermatomyositis (second of two parts).  N Engl J Med. 1975;  292(8) 403-407
  • 30 Fleckenstein J L, Reimers C D. Inflammatory myopathies: radiologic evaluation.  Radiol Clin North Am. 1996;  34(2) 427-439, xii
  • 31 Anthony D CFM, De Girolami U. Peripheral nerve and skeletal muscle. In: Kumar VAA, Fausto N, Aster J Robbins and Cotran Pathologic Basis of Disease. 8th ed. Philadelphia, PA; Saunders 2010: 1257-1277
  • 32 Cantwell C, Ryan M, O'Connell M et al.. A comparison of inflammatory myopathies at whole-body turbo STIR MRI.  Clin Radiol. 2005;  60(2) 261-267
  • 33 Askanas V, Engel W K. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis.  Curr Opin Rheumatol. 2007;  19(6) 550-559
  • 34 Palmer W E, Kuong S J, Elmadbouh H M. MR imaging of myotendinous strain.  AJR Am J Roentgenol. 1999;  173(3) 703-709
  • 35 De Smet A A. Magnetic resonance findings in skeletal muscle tears.  Skeletal Radiol. 1993;  22(7) 479-484
  • 36 Helms C A, Martinez S, Speer K P. Acute brachial neuritis (Parsonage-Turner syndrome): MR imaging appearance—report of three cases.  Radiology. 1998;  207(1) 255-259
  • 37 Kamath S, Venkatanarasimha N, Walsh M A, Hughes P M. MRI appearance of muscle denervation.  Skeletal Radiol. 2008;  37(5) 397-404
  • 38 Misamore G W, Lehman D E. Parsonage-Turner syndrome (acute brachial neuritis).  J Bone Joint Surg Am. 1996;  78(9) 1405-1408
  • 39 Kikuchi Y, Nakamura T, Takayama S, Horiuchi Y, Toyama Y. MR imaging in the diagnosis of denervated and reinnervated skeletal muscles: experimental study in rats.  Radiology. 2003;  229(3) 861-867
  • 40 Ryan M, Twair A, Nelson E, Brennan D, Eustace S. Whole body magnetic resonance imaging in the diagnosis of Parsonage Turner syndrome.  Acta Radiol. 2004;  45(5) 534-539
  • 41 Beltran J, Simon D C, Katz W, Weis L D. Increased MR signal intensity in skeletal muscle adjacent to malignant tumors: pathologic correlation and clinical relevance.  Radiology. 1987;  162(1 Pt 1) 251-255
  • 42 May D A, Good R B, Smith D K, Parsons T W. MR imaging of musculoskeletal tumors and tumor mimickers with intravenous gadolinium: experience with 242 patients.  Skeletal Radiol. 1997;  26(1) 2-15
  • 43 Weatherall P. Imaging of muscle tumors.  Semin Musculoskelet Radiol. 2000;  4(4) 435-458
  • 44 Rosenberg A. Bones, joints, and soft tissue tumors. In: Cotran RS, Robbins SL, Collins T, Kumar V Robbins Pathologic Basis of Disease. 6th ed. Philadelphia, PA; Saunders 1999: 1259-1267
  • 45 Stein-Wexler R. MR imaging of soft tissue masses in children.  Magn Reson Imaging Clin N Am. 2009;  17(3) 489-507
  • 46 Shelly M J, MacMahon P J, Eustace S. Radiology of soft tissue tumors including melanoma.  Cancer Treat Res. 2008;  143 423-452
  • 47 Pappo A S, Shapiro D N, Crist W M. Rhabdomyosarcoma. Biology and treatment.  Pediatr Clin North Am. 1997;  44(4) 953-972
  • 48 Yousem D M, Lexa F J, Bilaniuk L T, Zimmerman R I. Rhabdomyosarcomas in the head and neck: MR imaging evaluation.  Radiology. 1990;  177(3) 683-686
  • 49 Fleckenstein J L, Watumull D, Conner K E et al.. Denervated human skeletal muscle: MR imaging evaluation.  Radiology. 1993;  187(1) 213-218
  • 50 Ozsarlak O, Parizel P M, De Schepper A M, De Jonghe P, Martin J J. Whole-body MR screening of muscles in the evaluation of neuromuscular diseases.  Eur Radiol. 2004;  14(8) 1489-1493
  • 51 Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future.  J Magn Reson Imaging. 2007;  25(2) 433-440
  • 52 Liu G C, Jong Y J, Chiang C H, Jaw T S. Duchenne muscular dystrophy: MR grading system with functional correlation.  Radiology. 1993;  186(2) 475-480
  • 53 Messineo D, Cremona A, Trinci M, Francia A, Marini A. MRI in the study of distal primary myopathies and of muscular alterations due to peripheral neuropathies: possible diagnostic capacities of MR equipment with low intensity field (0.2 T) dedicated to peripheral limbs.  Magn Reson Imaging. 1998;  16(7) 731-741
  • 54 Lamminen A E. Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement.  Br J Radiol. 1990;  63(756) 946-950
  • 55 Ozsarlak O, Schepens E, Parizel P M et al.. Hereditary neuromuscular diseases.  Eur J Radiol. 2001;  40(3) 184-197
  • 56 Pichiecchio A, Uggetti C, Egitto M G et al.. Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy.  Eur Radiol. 2002;  12(11) 2704-2709
  • 57 Manzur A Y, Muntoni F. Diagnosis and new treatments in muscular dystrophies.  J Neurol Neurosurg Psychiatry. 2009;  80(7) 706-714
  • 58 Schreiber A, Smith W L, Ionasescu V et al.. Magnetic resonance imaging of children with Duchenne muscular dystrophy.  Pediatr Radiol. 1987;  17(6) 495-497
  • 59 Schara U, Schoser B G. Myotonic dystrophies type 1 and 2: a summary on current aspects.  Semin Pediatr Neurol. 2006;  13(2) 71-79
  • 60 Day J W, Ricker K, Jacobsen J F et al.. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.  Neurology. 2003;  60(4) 657-664
  • 61 Wheeler T M, Thornton C A. Myotonic dystrophy: RNA-mediated muscle disease.  Curr Opin Neurol. 2007;  20(5) 572-576
  • 62 Kornblum C, Lutterbey G, Bogdanow M et al.. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study.  J Neurol. 2006;  253(6) 753-761
  • 63 Damian M S, Bachmann G, Herrmann D, Dorndorf W. Magnetic resonance imaging of muscle and brain in myotonic dystrophy.  J Neurol. 1993;  240(1) 8-12
  • 64 Castillo J, Pumar J M, Rodríguez J R et al.. Magnetic resonance imaging of muscles in myotonic dystrophy.  Eur J Radiol. 1993;  17(3) 141-144
  • 65 Fleckenstein J L. MRI of neuromuscular disease: the basics.  Semin Musculoskelet Radiol. 2000;  4(4) 393-419
  • 66 Brennan D D, Whelan P F, Robinson K et al.. Rapid automated measurement of body fat distribution from whole-body MRI.  AJR Am J Roentgenol. 2005;  185(2) 418-423

Martin J ShellyM.D. 

Department of Radiology, Mater Misericordiae University Hospital

Eccles St., Dublin 7, Ireland

Email: martinshelly@gmail.com